logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Anticoagulants Antiplatelets And Thrombolytics 1st Edition Shaker A Mousa

  • SKU: BELL-927380
Anticoagulants Antiplatelets And Thrombolytics 1st Edition Shaker A Mousa
$ 31.00 $ 45.00 (-31%)

0.0

0 reviews

Anticoagulants Antiplatelets And Thrombolytics 1st Edition Shaker A Mousa instant download after payment.

Publisher: Humana Press
File Extension: PDF
File size: 1.94 MB
Pages: 293
Author: Shaker A. Mousa
ISBN: 9781617373466, 161737346X
Language: English
Year: 2010
Edition: 1st Edition.

Product desciption

Anticoagulants Antiplatelets And Thrombolytics 1st Edition Shaker A Mousa by Shaker A. Mousa 9781617373466, 161737346X instant download after payment.

This practical collection provides a comprehensive update on clinically relevant in vitro and in vivo models of thrombosis and hemostasis for the discovery and testing of antithrombotics, and summarizes recent development in pharmaceuticals for the prevention and treatment of various thromboembolic disorders. Topics of the 17 contributions include low molecular weight heparins, antithrombotic drugs for the treatment of heparin-induced thrombocytopenia, guidelines for the diagnosis of deep venous thrombosis and pulmonary embolism, the development of both small and large animal models, the characteristics of factor Xa inhibitors, and the development of therapeutic candidates based on cell adhesion molecules.

Related Products